HIV seroincidence and risk factors among patients repeatedly tested for HIV attending sexually transmitted disease clinics in the United States, 1991 to 1996

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 19, Issue 5, 1998, Pages 506-512

  Weinstock, Hillard ^a,b   Sweeney, Susan ^a   Satten, Glen A ^a   Gwinn, Marta ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

HIV 1; Homosexuality; Incidence; Sexually transmitted diseases

Indexed keywords

ADULT; ARTICLE; FEMALE; HIGH RISK POPULATION; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEROCONVERSION; SEXUALLY TRANSMITTED DISEASE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0032534850     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199812150-00010     Document Type: Article

References (36)

1. Karon JM, Rosenberg PS, McQuillan G, Khare M, Gwinn M, Petersen LR. Prevalence of HIV infection in the United States, 1984 to 1992. JAMA 1996;276:126-31.
2. Holmberg SD. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Public Health 1996;86:642-54.
3. Rosenberg PS. Scope of the AIDS epidemic in the United States. Science 1995;270:1372-5.
4. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report 1997;9:31.
5. Centers for Disease Control and Prevention. National HIV serosurveillance summary - results through 1992. Atlanta: U.S. Department of Health and Human Services, Public Health Service, 1993.
6. Cannon RO, Schmid GP, Moore PS, Pappaioanou M. Human immunodeficiency virus (HIV) seroprevalence in persons attending STD clinics in the United States, 1985-1987. Sex Transm Dis 1989;16:184-9.
7. Quinn TC, Glasser D, Cannon RO, et al. Human immunodeficiency virus infection among patients attending clinics for sexually transmitted diseases. N Engl J Med 1988;318:197-203.
8. McCray E, Onorato IM. Sentinel surveillance of human immunodeficiency virus infection in sexually transmitted disease clinics in the United States. Sex Transm Dis 1992;19:235-41.
9. Quinn TC, Groseclose SL, Spence M, Provost V, Hook EW. Evolution of the human immunodeficiency virus epidemic among patients attending sexually transmitted disease clinics: a decade of experience. J Infect Dis 1992;165:541-4.
10. Weinstock HS, Sidhu J, Gwinn M, Karon J, Petersen LR. Trends in HIV seroprevalence among persons attending sexually transmitted disease clinics in the United States, 1988-1992. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:514-22.
11. Peterman TA, Zaidi AA, Wroten J. Decreasing prevalence hides a high HIV incidence: Miami. AIDS 1995;9:965-70.
12. Batter V, Matela B, Nsuami M, et al. High HIV-1 incidence in young women masked by stable overall seroprevalence among childbearing women in Kinshasa, Zaire: estimating incidence from serial seroprevalence data. AIDS 1994;8:811-17.
13. Onorato IM, Klaskala W, Morgan WM, Withum D. Prevalence, incidence, and risks for HIV-1 infection in female sex workers in Miami, Florida. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:395-400.
14. SAS Institute, Inc. The LIFEREG procedure, In: SAS/STAT user's guide. Cary, NC: SAS Institute, 1989:641-66.
15. Centers for Disease Control and Prevention. Update: AIDS among women-United States, 1994. MMWR Morbid Mortal Wkly Rep 1995;44:81-4.
16. Centers for Disease Control and Prevention. Heterosexually acquired AIDS-United States, 1993. MMWR Morbid Mortal Wkly Rep 1994;43:155-60.
17. Miller E, Waight PA, Tedder RS, Sutherland S, Mortimer PP, Shafi MS. Incidence of HIV infection in homosexual men in London, 1988-94. BMJ 1995;311:545.
18. Buchbinder SP, Douglas JM Jr, McKirnan DJ, Judson FN, Katz MH, MacQueen KM. Feasibility of human immunodeficiency virus vaccine trials in homosexual men in the United States: risk behavior, seroincidence, and willingness to participate. J Infect Dis 1996;174:954-61.
19. Lemp GF, Hirozawa AM, Givertz D, et al. Seroprevalence of HIV and risk behaviors among young homosexual and bisexual men: the San Francisco/Berkeley Young Men's Survey. JAMA 1994; 272:449-54.
20. Winkelstein W, Wiley JA, Padian NS, et al. The San Francisco men's health study: continued decline in HIV seroconversion rates among homosexual/bisexual men. Am J Public Health 1988;78: 1472-4.
21. Kingsley LA, Zhou SY, Bacellar H, et al. Temporal trends in human immunodeficiency virus type 1 seroconversion 1984-1989. A report from the Multicenter AIDS Cohort Study (MACS). Am J Epidemiol 1991;134:331-9.
22. van Griensven GJ, de Vroome EM, Goudsmit J, Coutinho RA. Changes in sexual behaviour and the fall in incidence of HIV infection among homosexual men. BMJ 1989;298:218-21.
23. Hessol NA, Lifson AR, O'Malley PM, Doll LS, Jaffe HW, Rutherford GW. Prevalence, incidence, and progression of human immunodeficiency virus infection in homosexual and bisexual men in hepatitis B vaccine trials: 1978-1988. Am J Epidemiol 1989;130: 1167-75.
24. Centers for Disease Control and Prevention. Update: trends in AIDS incidence, deaths, and prevalence - United States, 1996. MMWR Morbid Mortal Wkly Rep 1997;46:165-73.
25. McCray E, Onorato IM. Sentinel surveillance of human immunodeficiency virus infection in sexually transmitted disease clinics in the United States. Sex Transm Dis 1992;19:235-41.
26. Allen DM, Onorato IM, Green TA, Field Services Branch of the Centers for Disease Control. HIV infection in intravenous drug users entering drug treatment, United States, 1988 to 1989. Am J Public Health 1992;82:541-6.
27. Prevots DR, Allen DM, Lehman JS, Green TA, Petersen LR, Gwinn M. Trends in human immunodeficiency virus seroprevalence among injection drug users entering drug treatment centers, United States, 1988-1993. Am J Epidemiol 1996;143:733-42.
28. Wasserheit JN. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 1992;19:61-77.
29. Kassler W, Zenilman JM, Erickson B, Fox R, Peterman TA, Hook EW. Seroconversion in patients attending sexually transmitted disease clinics. AIDS 1994;8:351-5.
30. Mehendale SM, Rodrigues JJ, Brookmeyer RS, et al. Incidence and predictors of human immunodeficiency virus type 1 seroconversion in patients attending sexually transmitted disease clinics in India. J Infect Dis 1995;172:1486-91.
31. Moss GB, Overbaugh J, Welch M, et al. Human immunodeficiency virus dna in urethral secretions in men: association with gonococcal urethritis and CD4 cell depletion. J Infect Dis 1995;172:1469-74.
32. Ghys PD. The associations between cervico-vaginal HIV-1 shedding and sexually transmitted diseases, immunosuppression, and serum HIV-1 viral load in female sex workers in Abidjan, Cote D'Ivoire [abstract]. Presented at the XI International Conference on AIDS, Vancouver, British Columbia, Canada, July, 1996.
33. Cohen MS, Hoffman I, Royce R, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. Lancet 1997;349: 1868-73.
34. Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995;346:530-36.
35. Carpenter CC, Fischl MA, Hammer SM, et al. Antiretroviral therapy of HIV infection in 1997: updated recommendations of the International AIDS Society - USA panel. JAMA 1997;277: 1962-9.
36. Koopman JS, Jacquez JA, Welch GW, et al. The role of early HIV infection in the spread of HIV through populations. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:249-58.